Synthetic Glycovaccine Protects against the Bite ofLeishmania‐Infected Sand Flies
Open Access
- 15 August 2006
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 194 (4) , 512-518
- https://doi.org/10.1086/505584
Abstract
Leishmaniasis is a vectorborne disease transmitted to human and other mammalian hosts by sand fly bite. In the present study, we show that immunizatiKeywords
This publication has 40 references indexed in Scilit:
- Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?Immunological Reviews, 2004
- Re‐examination of the immunosuppressive mechanisms mediating non‐cure of Leishmania infection in miceImmunological Reviews, 2004
- The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine developmentImmunological Reviews, 2004
- Inhibition of Lipopolysaccharide-Induced Macrophage IL-12 Production byLeishmania mexicanaAmastigotes: The Role of Cysteine Peptidases and the NF-κB Signaling PathwayThe Journal of Immunology, 2004
- New Insights into the Developmental Biology and Transmission Mechanisms of LeishmaniaCurrent Molecular Medicine, 2004
- A Synthetic Conjugate Polysaccharide Vaccine Against Haemophilus influenzae Type bScience, 2004
- Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasisVaccine, 2004
- Bacterial polysaccharide–protein conjugate vaccinesBritish Medical Bulletin, 2004
- Persistence Without Pathology in Phosphoglycan-Deficient Leishmania majorScience, 2003
- Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.The Journal of Immunology, 1987